Physical and chemical microenvironmental cues orthogonally control the degree and duration of fibrosis‐associated epithelial‐to‐mesenchymal transitions

Increased tissue stiffness and epithelial‐to‐mesenchymal transitions (EMTs) are two seemingly discrete hallmarks of fibrotic diseases. Despite recent findings highlighting the influence of tissue mechanical properties on cell phenotype, it remains unclear what role increased tissue stiffness has in the regulation of previously reported fibronectin‐mediated EMTs associated with pulmonary fibrosis. Nano‐indentation testing of lung interstitial spaces showed that in vivo cell‐level Young's moduli increase with the onset of fibrosis from ∼2 to ∼17 kPa. In vitro, we found that stiff, but not soft, fibronectin substrates induce EMT, a response dependent on cell contraction‐mediated integrin activation of TGFβ. Activation or suppression of cell contractility with exogenous factors was sufficient to overcome the effect of substrate stiffness. Pulse‐chase experiments indicate that the effect of cell contractility is dose‐ and time‐dependent. In response to low levels of TGFβ on soft surfaces, either added exogenously or produced through thrombin‐induced contraction, cells will initiate the EMT programme, but upon removal revert to an epithelial phenotype. These results identify matrix stiffness and/or cell contractility as critical targets for novel therapeutics for fibrotic diseases.

[1]  T. Suga,et al.  Notch induces myofibroblast differentiation of alveolar epithelial cells via transforming growth factor-{beta}-Smad3 pathway. , 2011, American journal of respiratory cell and molecular biology.

[2]  T. Walz,et al.  Latent TGF-β structure and activation , 2011, Nature.

[3]  W. Coward,et al.  The pathogenesis of idiopathic pulmonary fibrosis , 2010, Therapeutic advances in respiratory disease.

[4]  C. Wai,et al.  Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment , 2010, Nature Medicine.

[5]  A. Kho,et al.  Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression , 2010, The Journal of cell biology.

[6]  A. Engler,et al.  Preparation of Hydrogel Substrates with Tunable Mechanical Properties , 2010, Current protocols in cell biology.

[7]  J. Hagood,et al.  Thy-1-Integrin αvβ5 Interactions Inhibit Lung Fibroblast Contraction-induced Latent Transforming Growth Factor-β1 Activation and Myofibroblast Differentiation* , 2010, The Journal of Biological Chemistry.

[8]  J. Sznajder,et al.  Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[9]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[10]  B. Willis,et al.  N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[11]  E. Wouters,et al.  Rehabilitation and palliative care in lung fibrosis. , 2009 .

[12]  D. E. Discher,et al.  Matrix elasticity directs stem cell lineage — Soluble factors that limit osteogenesis , 2009 .

[13]  Samy Lamouille,et al.  TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.

[14]  A. Shoukas,et al.  Decreased S-Nitrosylation of Tissue Transglutaminase Contributes to Age-Related Increases in Vascular Stiffness , 2008, Circulation research.

[15]  B. Hinz,et al.  Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix , 2007, The Journal of cell biology.

[16]  Kheya Sengupta,et al.  Fibroblast adaptation and stiffness matching to soft elastic substrates. , 2007, Biophysical journal.

[17]  P. Janmey,et al.  Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[18]  Samy Lamouille,et al.  Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway , 2007, The Journal of cell biology.

[19]  Xi-xi Cao,et al.  [Effect of Smad7 on transforming growth factor-beta1-induced alveolar epithelial to mesenchymal transition]. , 2007, Zhonghua yi xue za zhi.

[20]  P. Shaul,et al.  Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1. , 2007, American journal of respiratory cell and molecular biology.

[21]  In‐San Kim,et al.  Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition. , 2007, Journal of the American Society of Nephrology : JASN.

[22]  H. Nakano,et al.  Cell contact-dependent regulation of epithelial-myofibroblast transition via the rho-rho kinase-phospho-myosin pathway. , 2007, Molecular biology of the cell.

[23]  F Verrecchia,et al.  [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.

[24]  D. Sheppard,et al.  Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix , 2006, Proceedings of the National Academy of Sciences.

[25]  G. FitzGerald,et al.  COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[26]  M. Selman,et al.  Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. , 2006, Proceedings of the American Thoracic Society.

[27]  R. Chambers,et al.  Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. , 2006, The Journal of clinical investigation.

[28]  M. Sheetz,et al.  Local force and geometry sensing regulate cell functions , 2006, Nature Reviews Molecular Cell Biology.

[29]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[30]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[31]  R. Mason,et al.  TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) , 2005, Respiratory research.

[32]  C. McCulloch,et al.  Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. , 2004, The American journal of pathology.

[33]  Adam J. Engler,et al.  Myotubes differentiate optimally on substrates with tissue-like stiffness , 2004, The Journal of cell biology.

[34]  Christiane Cantin,et al.  Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-β and Neu pathway signaling studies: identification of a novel model for TGF-β-induced epithelial-to-mesenchymal transition , 2004, Breast Cancer Research.

[35]  J. Settleman,et al.  Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity. , 2004, Experimental cell research.

[36]  C. Der,et al.  ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix , 2003, The Journal of cell biology.

[37]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[38]  Y. Wang,et al.  Cell locomotion and focal adhesions are regulated by the mechanical properties of the substrate. , 1998, The Biological bulletin.

[39]  Y. Wang,et al.  Cell locomotion and focal adhesions are regulated by substrate flexibility. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Rifkin,et al.  An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. , 1994, Analytical biochemistry.

[41]  J. Taipale,et al.  Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. , 1992, The Journal of biological chemistry.

[42]  Ashley C. Brown,et al.  Guiding epithelial cell phenotypes with engineered integrin-specific recombinant fibronectin fragments. , 2011, Tissue engineering. Part A.

[43]  P. Shaul,et al.  Endothelin-1 Induces Alveolar Epithelial–Mesenchymal Transition through Endothelin Type A Receptor–Mediated Production of TGF- (cid:2) 1 , 2007 .

[44]  P. Janmey,et al.  Biomechanics and Mechanotransduction in Cells and Tissues Cell type-specific response to growth on soft materials , 2005 .

[45]  A. Nicholson,et al.  Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. , 2005, The American journal of pathology.

[46]  C. McCulloch,et al.  Integrity of Cell-Cell Contacts Is a Critical Regulator of TGF- (cid:1) 1-Induced Epithelial-to-Myofibroblast Transition Role for (cid:1) -Catenin , 2004 .

[47]  J. Munger,et al.  Integrin (cid:1) V 6 -mediated activation of latent TGF- (cid:2) requires the latent TGF- (cid:2) binding protein-1 , 2004 .